<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cui X</submitter><funding>Natural Science Foundation of Shanxi</funding><pagination>216</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12487243</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Premature ovarian failure (POF) is a debilitating condition impairing fertility and health in women. Mesenchymal stem cell-derived exosomes (MSC-EVs) have emerged as a promising therapeutic option for POF due to their regenerative capabilities. This study explores the effectiveness of human umbilical cord mesenchymal stem cell-derived exosomes (HuMSCs-Exos) in counteracting NLRP3-mediated pyroptosis and restoring ovarian function in a cyclophosphamide (CTX)-induced POF model.&lt;h4>Methods&lt;/h4>HuMSCs-Exos were characterized using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blot for exosomal markers. A CTX-induced POF mouse model was treated with HuMSCs-Exos to assess their impact on ovarian morphology, function, and fertility. A</pubmed_abstract><journal>Journal of ovarian research</journal><pubmed_title>Exosomes derived from mesenchymal stem cells repair ovarian function by suppressing NLRP3-mediated pyroptosis in cyclophosphamide-induced premature ovarian failure.</pubmed_title><pmcid>PMC12487243</pmcid><funding_grant_id>201901D211519</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Jing X</pubmed_authors><pubmed_authors>Xue T</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Cui X</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exosomes derived from mesenchymal stem cells repair ovarian function by suppressing NLRP3-mediated pyroptosis in cyclophosphamide-induced premature ovarian failure.</name><description>&lt;h4>Background&lt;/h4>Premature ovarian failure (POF) is a debilitating condition impairing fertility and health in women. Mesenchymal stem cell-derived exosomes (MSC-EVs) have emerged as a promising therapeutic option for POF due to their regenerative capabilities. This study explores the effectiveness of human umbilical cord mesenchymal stem cell-derived exosomes (HuMSCs-Exos) in counteracting NLRP3-mediated pyroptosis and restoring ovarian function in a cyclophosphamide (CTX)-induced POF model.&lt;h4>Methods&lt;/h4>HuMSCs-Exos were characterized using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and western blot for exosomal markers. A CTX-induced POF mouse model was treated with HuMSCs-Exos to assess their impact on ovarian morphology, function, and fertility. A</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-05-04T03:14:13.121Z</modification><creation>2026-05-04T03:13:03.088Z</creation></dates><accession>S-EPMC12487243</accession><cross_references><pubmed>41034911</pubmed><doi>10.1186/s13048-025-01785-1</doi></cross_references></HashMap>